The visit with you and Ken last month was certainly very productive.
You should know that David Baltimore is far and away the front runner as director-apparent, and he will have a major role
in further choices and discussions. My assay of site preferences at this time -- and this is subject to modulation by other
aspects of a concordat -- is:
We (RU) will, I am sure, make some offer to Jack and Dave that will at least roughly match what we discussed for
[END PAGE ONE]
[BEGIN PAGE TWO]
Stanford. But the different valuation of real estate makes it hard to generate [?] a symmetrical perspective. Obviously much
will hinge on what Dave can get from MIT that would match his preferences. But I think he would seriously consider alternatives
if that doesn't work out.
So don't let this get to be torpedoed at Stanford -- for the wrong reasons -- as happened last time.
The important goal is to be sure that 150M plus dollars does come to biomedical research, no matter where.